638 related articles for article (PubMed ID: 23712734)
1. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
Tjon JA; Pe M; Soscia J; Mahant S
Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
3. The use of proton pump inhibitors in children: a comprehensive review.
Gibbons TE; Gold BD
Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
Cohen S; Bueno de Mesquita M; Mimouni FB
Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of long-term use of proton pump inhibitors in children.
De Bruyne P; Ito S
Arch Dis Child; 2018 Jan; 103(1):78-82. PubMed ID: 29237614
[TBL] [Abstract][Full Text] [Related]
7. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
Orenstein SR; Hassall E; Furmaga-Jablonska W; Atkinson S; Raanan M
J Pediatr; 2009 Apr; 154(4):514-520.e4. PubMed ID: 19054529
[TBL] [Abstract][Full Text] [Related]
8. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
[TBL] [Abstract][Full Text] [Related]
9. Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease.
Kierkus J; Oracz G; Korczowski B; Szymanska E; Wiernicka A; Woynarowski M
Drug Saf; 2014 May; 37(5):309-16. PubMed ID: 24706290
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics.
Ward RM; Kearns GL
Paediatr Drugs; 2013 Apr; 15(2):119-31. PubMed ID: 23512128
[TBL] [Abstract][Full Text] [Related]
11. Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review.
Miyazaki H; Igarashi A; Takeuchi T; Teng L; Uda A; Deguchi H; Higuchi K; Tango T
J Gastroenterol Hepatol; 2019 Aug; 34(8):1316-1328. PubMed ID: 30883868
[TBL] [Abstract][Full Text] [Related]
12. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
Jonasson C; Tvete IF; Hatlebakk JG
Scand J Gastroenterol; 2013 Sep; 48(9):1010-7. PubMed ID: 23859491
[TBL] [Abstract][Full Text] [Related]
13. Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease.
Miwa H; Igarashi A; Teng L; Uda A; Deguchi H; Tango T
J Gastroenterol; 2019 Aug; 54(8):718-729. PubMed ID: 30919071
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
Savarino V; Di Mario F; Scarpignato C
Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor use and enteric infections.
Dial MS
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
[TBL] [Abstract][Full Text] [Related]
17. European pediatricians' approach to children with GER symptoms: survey of the implementation of 2009 NASPGHAN-ESPGHAN guidelines.
Quitadamo P; Papadopoulou A; Wenzl T; Urbonas V; Kneepkens CM; Roman E; Orel R; Pavkov DJ; Dias JA; Vandenplas Y; Kostovski A; Miele E; Villani A; Staiano A
J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):505-9. PubMed ID: 24663035
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use in infants: FDA reviewer experience.
Chen IL; Gao WY; Johnson AP; Niak A; Troiani J; Korvick J; Snow N; Estes K; Taylor A; Griebel D
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):8-14. PubMed ID: 21946832
[TBL] [Abstract][Full Text] [Related]
19. Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
Cheng Y; Liu J; Tan X; Dai Y; Xie C; Li X; Lu Q; Kou F; Jiang H; Li J
Dig Dis Sci; 2021 Jan; 66(1):19-28. PubMed ID: 32095968
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy.
Romano C; Chiaro A; Comito D; Loddo I; Ferrau V
Curr Clin Pharmacol; 2011 Feb; 6(1):41-7. PubMed ID: 21235462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
